Global AI in Neurodegenerative Disease Prediction Market - Strategic Insights and Forecasts (2026-2035)

The Global AI in Neurodegenerative Disease Prediction Market is projected to grow from USD 0.59 billion in 2026 to USD 3.07 billion by 2035, at a CAGR of 20.1% during the forecast period.

The Global AI in Neurodegenerative Disease Prediction Market is growing due to rising aging populations, increasing dementia cases, expansion of disease-modifying therapies, and greater adoption of AI-based diagnostic and predictive healthcare systems.

The Global AI in Neurodegenerative Disease Prediction Market primarily focuses on Alzheimer’s disease, followed by Parkinson’s disease, ALS, and Huntington’s disease due to their high clinical burden and availability of research data.

The Global AI in Neurodegenerative Disease Prediction Market faces challenges such as limited standardized neurological datasets, regulatory compliance requirements, and concerns regarding AI explainability and transparency.

The Global AI in Neurodegenerative Disease Prediction Market offers opportunities in biomarker discovery, federated learning, retinal and digital biomarker analytics, and community-based neurological screening programs.